These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 1335667)

  • 1. Who should receive hepatitis A vaccine? Considerations for the development of an immunization strategy.
    Margolis HS; Shapiro CN
    Vaccine; 1992; 10 Suppl 1():S85-7. PubMed ID: 1335667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Considerations for the development of recommendations for the use of hepatitis A vaccine.
    Margolis HS; Shapiro CN
    J Hepatol; 1993; 18 Suppl 2():S56-60. PubMed ID: 8182276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries.
    Das A
    Hepatology; 1999 Feb; 29(2):548-52. PubMed ID: 9918934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vaccination against hepatitis A].
    Giusti G; Russo M
    Recenti Prog Med; 1992 Jun; 83(6):313-20. PubMed ID: 1323136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives on the control of hepatitis A by vaccination.
    Kane MA
    Vaccine; 1992; 10 Suppl 1():S93-6. PubMed ID: 1335670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of hepatitis A prevention in travellers.
    Tormans G; Van Damme P; Van Doorslaer E
    Vaccine; 1992; 10 Suppl 1():S88-92. PubMed ID: 1335668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of immunization against hepatitis A.
    Lemon SM; Shapiro CN
    Infect Agents Dis; 1994 Feb; 3(1):38-49. PubMed ID: 7952926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current seroepidemiological status of hepatitis A with a comparison of antibody titers after infection and vaccination.
    Fujiyama S; Odoh K; Kuramoto I; Mizuno K; Tsurusaki R; Sato T
    J Hepatol; 1994 Oct; 21(4):641-5. PubMed ID: 7814811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis A and hepatitis B: risks compared with other vaccine preventable diseases and immunization recommendations.
    Steffen R
    Vaccine; 1993; 11(5):518-20. PubMed ID: 8387717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Seroepidemiology of hepatitis A virus infection in medical and nursing students. The role of vaccination].
    Buti M; Campins M; Jardí R; Navas E; Cotrina M; Llobet E; Vaqué J; Esteban R
    Gastroenterol Hepatol; 1996 Apr; 19(4):199-202. PubMed ID: 8665357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic treatment regimens for the prevention of hepatitis A. Current concepts.
    Kendall BJ; Cooksley WG
    Drugs; 1991 Jun; 41(6):883-8. PubMed ID: 1715265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult use of hepatitis A vaccine in developed countries.
    Jilg W
    Vaccine; 1993; 11 Suppl 1():S6-8. PubMed ID: 8383389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivated hepatitis A vaccine: active and passive immunoprophylaxis in chimpanzees.
    Purcell RH; D'Hondt E; Bradbury R; Emerson SU; Govindarajan S; Binn L
    Vaccine; 1992; 10 Suppl 1():S148-51. PubMed ID: 1335648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current status and vaccine indication for hepatitis A virus infection in Korea].
    Jeong SH
    Korean J Gastroenterol; 2008 Jun; 51(6):331-7. PubMed ID: 18604134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence of anti-hepatitis A in patients with chronic liver disease].
    Diago M; Luján M; García V; Cors R; Carbonell P; Tuset C; Gimeno J
    Gastroenterol Hepatol; 1998; 21(7):324-6. PubMed ID: 9808894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of viral hepatitis A: past, present and future.
    Deinhardt F
    Vaccine; 1992; 10 Suppl 1():S10-4. PubMed ID: 1335635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance for acute viral hepatitis - United States, 2007.
    Daniels D; Grytdal S; Wasley A;
    MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on immunization strategy against hepatitis A in a highly prevalent area].
    Zhang Y; Ma J; Zhao S
    Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Sep; 32(5):295-6. PubMed ID: 10322776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effective analysis of hepatitis A prevention in Ireland.
    Rajan E; Shattock AG; Fielding JF
    Am J Gastroenterol; 2000 Jan; 95(1):223-6. PubMed ID: 10638588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress Toward Eliminating Hepatitis A Disease in the United States.
    Murphy TV; Denniston MM; Hill HA; McDonald M; Klevens MR; Elam-Evans LD; Nelson NP; Iskander J; Ward JD
    MMWR Suppl; 2016 Feb; 65(1):29-41. PubMed ID: 26916458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.